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An ovine adenovirus, which is phylogenetically distinct from the Mastadeno- and Aviadenoviruses, was used to construct
recombinants in which reporter genes were expressed from the OAV major late, or human cytomegalovirus promoters. It
was demonstrated by transgene expression that OAV could infect bovine nasal turbinate and rabbit kidney cells as well as
a range of human cell types, including lung and foreskin fibroblasts as well as liver, prostate, breast, colon, and retinal
lines. Some human lines, e.g., 293 and LNCaP were not detectably infected. Infection occurred even though OAV has a
fiber protein with a unique cell binding domain and a penton protein that lacks the integrin-binding Arg–Gly–Asp motif
which facilitates entry by human adenoviruses. Most cell lines showed little or no ill effect for several days after infection
but a prominent cytopathic effect appeared in fibroblasts after 3–4 days. However, no viral DNA synthesis was detected
and replication was abortive. Viral promoter activity during infection of nonpermissive cell types was assayed by RT-PCR.
Early promoter activity was detectable in some, but not all cell types. In a liver and a colon carcinoma cell line, none of
the promoters examined was significantly active, even when a higher multiplicity of infection was used. Major late promoter
activity was not detectable in any cell type. The lack of DNA replication and MLP function suggests that a critical transition
from early to late gene expression does not occur during abortive infection by OAV. q 1997 Academic Press
INTRODUCTION group comprises the avian Egg Drop syndrome virus-76,
bovine Ad type 7, and ovine adenovirus isolate OAV287
The large majority of adenoviruses (Ad) are members
(OAV), which was isolated from sheep in Western Austra-
of the Mastadenovirus genus. Several human adenovi-
lia (Peet et al., 1983; Boyle et al., 1994). OAV is consideredruses (Ad) have been characterized at the molecular level
to be the prototype of the third group as it was the firstand for Ad2 and Ad5 in particular, a more detailed under-
virus for which the nucleotide sequence was determinedstanding of the process of infection and replication has
(Vrati et al., 1995, 1996a,b). OAV has the smallest knownbeen developed over the past three decades. Human
Ad genome (29,579 bp) and a structure which furtherAds infect a wide variety of nondividing cell types, making
distinguishes it from the other groups. In addition, manythem potentially useful vectors for gene delivery. Animal
open reading frames show no detectable homology withAds of canine, murine, porcine, and bovine origin have
other Ads and the virus has at least one structural proteinalso been partially characterized (Raviprakash et al.,
(p28K) which has no counterpart in the Mastadeno- or1989; Dragulev et al., 1991; Kleiboeker, 1995; Mittal et
Aviadenoviruses. The structural proteins V and IX of theal., 1995; McCoy et al., 1996a,b). While these isolates
Mastadenoviruses are also missing from the OAV ge-often differ from each other in their nonessential E3 re-
nome, but these may be replaced in the virion by twogions, they appear to possess a similar repertoire of
other structural polypeptides whose identity is not knownstructural and nonstructural proteins, identified by homol-
(Vrati et al., 1996a).ogies with their Ad2/5 counterparts. The genome ar-
OAV is serologically distinct from most other ovine,rangement in these viruses is similar to that of the human
porcine, and bovine Ads but is weakly cross-reactive withAd2 prototype. In contrast, CELO, the best characterized
BAV-7 (Adair et al., 1986), which is in the same groupmember of the Aviadenoviruses has many unique open
(Harrach et al., 1997). From an analysis of its hexon andreading frames and a distinct genome arrangement (Chi-
penton proteins OAV is also expected to be serologicallyocca et al., 1996).
distinct from human Ads (Vrati et al., 1996a). The OAVBased on an analysis of their viral protease genes,
fiber protein has a shaft region which is predicted toAds can now be considered as three phylogenetically
contain 25 repeating units and a cell binding domaindistinct groups (Harrach et al., 1997). The Mastadenovi-
comprising only 120 residues, compared to 200 resi-ruses and Aviadenoviruses form two of these. The third
dues for Ad5 (Vrati et al., 1995). This suggests that OAV
recognizes a different primary receptor from the one re-1 To whom correspondence and reprint requests should be ad-
dressed. Fax: 61 2 9490 5005. E-mail: gerry.both@molsci.csiro.au. cently described for human Ads (Bergelson et al., 1997).
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polyadenylation (AATAAA) signals (Fig. 1). The reporter
gene VP7sc, derived from the rotavirus isolate SA11 (An-
drew et al., 1990) was functionally linked with the MLP/
TLS by cloning it in the correct orientation into the XhoI
site of pMT. Subsequently, the MLP/TLS elements of pMT
were replaced by an ApaI/HindIII fragment containing
the HCMV IE enhancer/promoter element. This was gen-
erated, using appropriate primers, by PCR amplification
FIG. 1. Key elements of plasmid pMT for assembly and subcloning of
of the region between bases 480 and 1313 of pCEP4expression cassettes. The OAV MLP/TLS elements (Vrati et al., 1996b),
(Invitrogen Corp., San Diego, CA). Expression cassettesmultiple cloning sites, tandem polyadenylation signal, and the ApaI/
were subcloned as ApaI/NotI fragments into pOAV200,NotI sites used for subcloning are shown.
a plasmid containing a full-length copy of the OAV ge-
nome with ApaI/NotI sites inserted at nonessential site
In addition, OAV penton lacks the Arg/Gly/Asp motif and I, between the pVIII and the fiber genes (Vrati et al.,
flanking sequences which facilitate binding and uptake 1996c), creating plasmids for the rescue of OAV204 and
of human Ads via certain classes of integrin which act OAV206 (Figure 2).
as a secondary receptor (Wickham et al., 1993; Mathias Recombinant OAV216 (Fig. 2), which expresses human
et al., 1994). Because of its distinctive cell attachment placental alkaline phosphatase (AP) from the HCMV pro-
proteins, it was not obvious whether OAV would be capa- moter, was also constructed. The AP coding sequences
ble of infecting other cell types, although its narrow host were excised from plasmid pAdCBhAP (obtained from
range (Boyle et al., 1994) suggested that infection, if it Dr. J. Wilson, University of Pennsylvania) by partial diges-
occurred, was likely to be abortive. tion with SalI. A 2.3-kb fragment was cloned into the
Recently an infectious clone of the OAV genome was XhoI site of a pMT-based plasmid in which the MLP
constructed and nonessential sites for insertion of gene sequences were replaced by the HCMV enhancer pro-
expression cassettes were identified. Procedures for res- moter (see above). The gene cassette was obtained as
cuing recombinant viruses from plasmids were also de- a 3.1-kb fragment by partial digestion with ApaI and
veloped (Vrati et al., 1996c; Xu et al., 1997). In the present complete digestion with NotI and subcloned into
study, recombinants in which OAV major late promoter pOAV200 cut with ApaI/NotI (Vrati et al., 1996c).
(MLP) or human cytomegalovirus (HCMV) promoters di-
rect the expression of a reporter gene were constructed Transfection of genomic DNA and virus recovery
and used to investigate the host range of OAV. It was from CSL503 cells
shown by transgene expression that OAV infects a vari-
Conditions for the transfection of CSL503 fetal ovineety of animal and human cell types. Further, an analysis
lung cells with pOAV100 and related plasmids have beenof viral DNA replication and promoter function showed
described (Vrati et al., 1996c). Prior to transfection, linearthat infection was abortive.
recombinant genomes were released from plasmids by
digestion with KpnI. The genome structures of rescuedMATERIALS AND METHODS
viruses were confirmed as correct by restriction enzyme
Construction of recombinant plasmids digestion. Viruses were propagated in sheep fetal lung
CSL503 cells as described (Boyle et al., 1994).
The identification of the OAV MLP and tripartite leader
sequences (TLS) by reverse transcription-PCR was de- Cell culture, virus infection, and expression
scribed previously (Vrati et al., 1996b). Gene expression
cassettes were assembled in plasmid pMT (Fig. 1) which Cells lines were originally obtained from the following
sources. CSL503 ovine embryo lung, CSL Ltd. (Parkville,contains OAV MLP sequences (bases 4861–5023 of the
genome) linked to the tripartite leader sequence (TLS) Victoria, Australia); bovine nasal turbinate, ATCC-
CRL1390; human 293 embryonic kidney, ATCC CRL-1573;(Vrati et al., 1996b). A 153-bp fragment containing the
MLP was generated from the viral genome by PCR using HepG2 liver carcinoma, ATCC 10741; HT29 human colon
carcinoma, ATCC HTB-38; LNCaP prostate cancer, ATCCprimers which introduced ApaI and NdeI sites at the 5*
and 3* ends, respectively, of the amplified fragment. The CRL-1740; PC-3 prostate cancer, Prof I. J. Fidler, M. D.
Anderson Centre; MCF-7 breast cancer, ATCC HTB-22;TLS element was similarly generated with 5* NdeI and
3* HindIII sites using RT-PCR to amplify cDNA from pIIIa RK-13 rabbit kidney cells, ATCC CCL-37; MRC-5 human
lung fibroblasts, NIBSC, Herts., UK; MM418 melanoma,transcripts (Vrati et al., 1995). MLP and TLS elements
were linked by cloning them into the ApaI and HindIII Prof. P. J. Russell, Oncology Research Centre, POWH
(NSW, Australia); HFF human foreskin fibroblast andsites of plasmid Bluescript KS/ (Stratagene, La Jolla, CA).
The HindIII/NotI sequences of Bluescript KS/ were then T47D-2 breast cancer, Dr. R. Reddell, CMRI (Westmead,
NSW, Australia).replaced with the HindIII/NotI linker containing tandem
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FIG. 2. Structures of recombinant ovine adenoviruses. The corresponding plasmids, e.g., pOAV200, differ from the viral genomes such that in the
plasmids, the inverted terminal repeats (ITRs) of the viral genomes are linked via KpnI sites to modified Bluescribe sequences (Vrati et al., 1996c).
The approximate location and orientation of promoters discussed in the text is indicated by arrows.
CSL503 and bovine nasal turbinate (BNT) cells were DNA and mRNA preparation and RT-PCR analyses
maintained in EMEM plus 10% fetal calf serum (FCS).
Cells were left uninfected or were infected at varying
Rabbit kidney (RK13) and human 911 embryonic retinal
multiplicities (20–100 PFU/cell) and left for 2–4 days.
cells (Fallaux et al., 1996) were maintained in MEM or Low-molecular-weight DNA was isolated by a modified
DMEM, respectively, plus 10% FCS. Human prostate can- Hirt extraction as described previously (White et al.,
cer lines PC3 and LNCaP, melanoma line MM418E, the 1984), except that DNA was pelleted by centrifugation at
colon carcinoma line HT29, and breast cancer lines 17,000 g for 30 min at 47. Polyadenylated mRNA was
MCF-7 and T47D-2 were propagated in RPMI plus 10% prepared from animal and human cell lines at various
heat inactivated FCS. Human MRC-5 lung and foreskin times between 12 and 96 h postinfection (pi) by oligo(dT)
fibroblasts (HFF) and liver carcinoma HepG2 cells were selection using QuickPrep Micro kits (Pharmacia Bio-
maintained in DMEM plus 10% FCS (heat inactivated tech). In a few cases, infection was allowed to proceed
for MRC-5 cells). Cells were infected with wild-type or for 6 days. cDNA primed by oligo(dT)15 was synthesized
recombinant viruses at a multiplicity of infection (m.o.i.) by AMV reverse transcriptase using a first strand synthe-
of 1–100 PFU/cell based on titers determined by plaque sis kit (Boehringer Mannheim). Based on the known OAV
assays in CSL503 cells. Virus was adsorbed to cells for genome sequence (Vrati et al., 1995, 1996a,b) and se-
30 min at 377 in a 60-mm dish containing 200 ml of me- quencing of clones obtained by RT-PCR, transcripts de-
dium. Infection was allowed to proceed for 24–60 h. Cells rived from the MLP and right-hand end promoters and
were then incubated in methionine-free medium for 1 – their splice sites were identified (Vrati et al., 1996b; Xu
2 h in the presence of [35S]methionine to label newly et al., 1997). Similarly, work using mRNA derived from
synthesized proteins. The rotavirus VP7sc protein was OAV-infected CSL503 cells has identified spliced tran-
recovered from cell lysates by immunoprecipitation using scripts derived from two promoters near the left-hand
a polyclonal VP7 antiserum (Whitfeld et al., 1987). Pro- end of the genome (LHP1, LHP2), the E2 promoter, and
teins recovered were analyzed by polyacrylamide gel two promoters adjacent to the proposed E4 region (E4P1
electrophoresis and detected by autoradiography or a and E4P2) (Fig. 2) (Khatri and Both, in preparation). To
Phosphorimager (Molecular Dynamics). Alternatively, permit an assessment of promoter activity in various cell
VP7sc expression was monitored by immunofluores- lines, primer pairs which produced these PCR products
cence using a polyclonal rabbit antiserum raised against were used to amplify transcripts present in abortively
rotavirus isolate SA11 (1/1000 dilution), followed by fluo- infected cells. The primers flanked known introns and
resceinated mouse anti-rabbit (1/200 dilution). AP ex- therefore amplified spliced transcripts while minimizing
pression by OAV216 was monitored by fixing cells with amplification of genomic DNA. Primers used for RT-PCR
0.5% glutaraldehyde and staining cells using an insoluble analysis, their locations in the genome and the observed
PCR products are summarized in Table 1. In addition,substrate (Sigma Fast, Sigma Chem Co., St. Louis, MO).
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TABLE 1 produced at 24, 36, and 48 h p.i. (Fig. 3A, lanes 4, 6, and
8), before the monolayer showed cytopathic effects (cpe).Summary of Promoters, Primers, and PCR Products
No expression was detected in uninfected cells (Fig. 3B,
PCR lane 2). CSL503 cells also produce a 34-kDa form of
Genomic products VP7sc (Fig. 3A, lanes 3–8) which was not seen in other
distance approx. cell types. Thus, the 153-bp MLP fragment had promoter
Promoter Primersa (bp)a size (bp)
activity. In BNT cells, where replication occurs at a re-
duced level, infection with OAV204 resulted only in weakLHP1 428–448 (/) 891 530b
1296–1319 (0) VP7sc expression by 60 h p.i. (Fig. 3B, lane 9). Similar
LHP2 585–609 (/) 1471 500c infection of RK13 cells did not produce detectable VP7sc
2035–2056 (0) expression at 36 hr p.i. (Fig. 3B, lane 5) or 72 h p.i. (not
MLP/penton 8112–8135 (/) 4427 700b
shown).12515–12539 (0)
The MLP/TLS elements were replaced by the HCMVMLP/hexon 8112–8135 (/) 7068 650b
15159–15180 (0) promoter in OAV206. Infection of CSL503 cells with
E2/DBP 18302–18323 (/) 3071 1000b OAV206 resulted in VP7sc expression which was detect-
21350–21373 (0) able continuously from 12 to 48 h p.i. (Fig. 3A, lanes 1,
E4P1 24414–24434 (/) 1823 720c
3, 5, and 7). However, the overall level of expression from26214–26237 (0) 470c
the MLP and HCMV promoters was similar. Infection ofE4P2 24414–24434 (/) 1575 470c
25966–25989 (0) BNT and RK cells with OAV206 (m.o.i. 20 PFU/cell) re-
RHend 26731–26746 (/) 2730 600d sulted in clear expression at 48 h p.i. in both cell lines
29442–29461 (0) 750d (Fig. 3C, lanes 2 and 3). Although cpe was observed for
Human GAPDH 287–298 (/) 842 500
both cell types, for RK13 cells, infection was abortive as743–763 (0)
no late protein synthesis was detected in infected cell
a Numbers according to GenBank Accession Nos. U40839, U31557, lysates by radiolabeling (data not shown). In BNT cells
U40837, U18755, and U40838. late structural proteins, e.g., hexon, were detected but
b This work. the virus replicated to a level 1 log10 lower than thec Khatri and Both, manuscript in preparation.
yield obtained from CSL503 cells (unpublished results).d Xu et al. (1997).
When OAV204 was used to infect the human PC-3 cell
line at an m.o.i. of 20 PFU/cell, no expression of VP7sc
was detected (data not shown), presumably because theRT-PCR analysis using primers which spanned introns
virus failed to enter, because the MLP was nonfunctional,E, F, and G of the human glyceraldehyde-3-phosphate
or because VP7sc was unstable in those cells. To distin-dehydrogenase (GAPDH) (GenBank Accession No.
guish between these possibilities, a range of human cellsM17851) (Table 1) was carried out to monitor the integrity
was infected with OAV206 under the same conditionsof RNA preparations. PCR amplification of viral cDNA
and VP7sc expression was monitored by radioimmuno-was carried out for 40 cycles using Taq polymerase (Boe-
precipitation at 48 h p.i. Expression was clearly detectedhringer Mannheim) using annealing conditions that were
in PC3 cells (Fig. 4A, lane 3), in the breast cancer linesclose to the Tm of the oligos.
T47D-2 and MCF-7 (Fig. 4A, lanes 5 and 8) and in MRC-
5 lung fibroblasts (Fig. 4A, lane 6) but not in LNCaP (Fig.
RESULTS 4A, lane 12) or the melanoma MM418E line (data not
shown). Expression was apparently lower compared withExpression of VP7sc by OAV204 and OAV206
that in CSL503 cells at 24 h p.i. (Fig. 4A, lane 10), because
the latter were permissive, allowing amplification of theThe OAV MLP (Vrati et al., 1996b) linked to the VP7sc
reporter gene (Andrew et al., 1990) in OAV204 (Fig. 2) genome copy number through DNA replication (see be-
low). Expression of VP7sc was also detected by immuno-was used initially to monitor infection and expression.
VP7sc is expressed as a 37-kDa or 42- to 45-kDa glyco- fluorescence in HepG2 cells at 48 h p.i. (Fig. 4B).
In pOAV216, VP7sc sequences were replaced by APprotein in the ER or at the cell surface, respectively (An-
drew et al., 1990). The ratio of these forms varies between under the control of the HCMV promoter (Fig. 2). AP
provided a more convenient assay for expression andcell types depending on the extent to which the protein
is transported and processed. allowed the number of infected cells to be accurately
determined. Infection of cells with OAV216 and stainingWhen permissive CSL503 cells were infected at an
m.o.i. of 20 PFU/cell with OAV204, expression of VP7sc for AP showed that MCF-7 cells were as efficiently in-
fected as CSL503 cells (Fig. 4B). Similar results werewas clearly detected by radioimmunoprecipitation. No
expression was detected in wild-type OAV-infected cells observed for T47D-2, HT29, and 911 cells (data not
shown). However, human embryonic kidney 293 cells(data not shown). Under replication-permissive condi-
tions in CSL503 cells substantial levels of VP7sc were and the LNCaP prostate line were not detectably infected
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FIG. 3. Expression of VP7sc in animal cells infected with recombinant viruses OAV204 and OAV206. (A) Lanes 1, 3, 5, and 7, infection of CSL503
cells with OAV206 carrying the HCMV (C) promoter. Lanes 2, 4, 6, and 8, infection with OAV204 carrying the MLP (M) promoter. Lane 9 contains
markers of the sizes indicated. In (B) and (C) CSL503, bovine nasal turbinate (BNT) and rabbit kidney (RK) cells were uninfected (U) or infected (I)
with OAV204 or OAV206, respectively. (B) Lanes 2, 3, CSL503 cells; lanes 4, 5, RK13 cells; lanes 6–9, BNT cells. (C) Lanes 1, 2, RK13 cells; lanes
3, 4; BNT cells. Marker proteins were run in (B) lane 1 and (C) lane 5. Cells were infected at an m.o.i. of 20 PFU/cell, radiolabeled, and harvested
at the times p.i. indicated. VP7sc expression was monitored by radioimmunoprecipitation.
(Fig. 4B and data not shown). In control experiments, been considered as the E1A/B region of Ad5, although
this region of OAV also codes for a structural protein,infection of 293 (data not shown) and LNCaP cells with
Ad5/CMV/VP7sc (Xu et al., 1995) (Fig. 4A, lanes 14 and p28K, and does not contain typical E1A genes (Vrati et
al., 1996a). In our revised genomic sequence (GenBank15) confirmed that the HCMV promoter was functional in
those cells. Although they were infected and expressed Accession No. U40839) the p28K ORF ends at nucleotide
238. RT-PCR, cloning and sequencing has so far identi-the transgene, MCF-7 (see below) HepG2 and HT29 cells
showed little or no other evidence of infection as judged fied two promoters (LHP1 and LHP2) which produce
rightward, spliced transcripts coding for a possible 9-by their appearance after 4–7 days, i.e., the infection
appeared relatively benign. However, MRC-5 and HFF kDa ORF and the putative E1B 19- and 55-kDa homologs
(Vrati et al., 1996a) and Khatri and Both, manuscript inmonolayers infected at an m.o.i. of 100 PFU/cell showed
significant deterioration after 3–4 days. This was much preparation). In CSL503 cells at least one LHP1 transcript
was detected at 12 and 24 h p.i. as a PCR fragment ofreduced at lower m.o.i.s, suggesting that the infection
was probably abortive and therefore self-limiting. 530 bp (Table 1). This product was also detected at 96
h p.i. in MRC-5 cells but not in any of the other cell lines
(Table 2). LHP2 transcripts are truncated at their 5* endsEarly promoter function in infected cells
relative to LHP1 transcripts but appear to be more abun-
The transcription map of the OAV genome is still being dant although the RT-PCR assay was not done quantita-
elucidated but, by comparison with other Ad genomes tively. Transcripts from the LHP2 promoter were detect-
and by RLM/RACE analyses (Schaeffer, 1995), numerous able in all cell types except HepG2 cells (summarized in
spliced transcripts and the approximate locations of sev- Table 2), although these cells were infected, as shown
eral OAV promoters have been identified (see Materials by VP7sc expression (Fig. 4B).
and Methods). Therefore, to investigate the point(s) at A comparison of the Ad5 and OAV sequences sug-
which infection was blocked, polyadenylated RNA was gested that the OAV E2 promoter might be located in the
prepared from the various cell types and RT-PCR analysis intergenic region between the 33K and pVIII genes, as
of transcripts (Tables 1 and 2) was carried out to monitor it is in Ad5 (Stillman et al., 1981). Using a PCR primer
the function of individual promoters. from this region together with one from DBP, a product
of 800 bp was amplified by RT-PCR using mRNA har-The left-hand end of the OAV genome has nominally
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FIG. 4. Infection of human cell lines with adenovirus recombinants. (A) Cells were (U) uninfected or infected (I) at an m.o.i. of 20 as indicated
with OAV206 or Ad5/CMV/VP7sc. VP7sc expression by OAV206 was monitored by radioimmunoprecipitation at 24 h p.i. (CSL503 cells) or 48 h p.i.
(other cells). Expression by the Ad5 virus was monitored at 24 and 48 h. Lanes 2, 3, prostate PC-3 cells; lanes 4, 5, breast T47D-2 cells; lanes 6,
7, MRC-5 lung fibroblasts; lanes 8, 9, breast MCF-7 cells; lanes 10, 11; CSL503 cells: lanes 12–16; LNCaP cells. The figure is a compilation of
multiple experiments. (B) CSL503, MCF-7, and 293 cell lines were infected with OAV216 at m.o.i.s of 0, 1, 10, or 100 PFU/cell and stained at 48 h
(CSL503) or 60 h (other cells) for AP expression. HepG2 cells were infected at m.o.i.s of 0, 20, or 100 PFU/cell and VP7sc expression was monitored
in nonpermeabilized cells by immunofluorescent staining (Andrew et al., 1990). (Top left) HepG2 cells shows the phase image of the panel below
it. The same gain setting for detection of immunofluorescence was used in the three relevant panels.
vested at 12, 24, and 48 h p.i. from OAV-infected CSL503 2 (lane 16), MCF-7 (lane 18), and RK13 cells (lane 20).
As expected, in LNCaP cells (lane 22), which were notcells (Fig. 5, lanes 2, 4, and 6). Nucleotide sequencing
detectably infected, no activity was seen.confirmed that this product was derived from a spliced
DBP transcript (Khatri and Both, manuscript in prepara- A transcript with the potential to code for one of three
tion). Similarly, RT-PCR analysis performed using RNA ORFs in the putative E4 region of the genome has also
prepared from other cell types infected at an m.o.i. of 20 been identified by RT-PCR, cloning, and sequencing
(Khatri and Both, manuscript in preparation). The tran-PFU/cell showed that the E2 promoter was active in PC-
3 (Fig. 5, lanes 8 and 10), MRC-5 (lanes 12 and 14), T47D- script is derived from one of two promoters (E4P1 and
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TABLE 2 dogenous OAV MLP could function in human cells, RT-
PCR analyses were carried out. mRNA was preparedSummary of OAV Promoter Activity in Infected Cells
from cell lines infected with OAV206 at an m.o.i. of 20
Promoter PFU/cell at 12 h–6 days p.i. Infected CSL503 and LNCaP
cells served as positive and negative controls, respec-
Cell Time LH end LH end E4 E4 RH tively. RT-PCR was used to amplify selected regions of
type pia P1 P1 / P2b MLP E2 P1 P2 end
late RNA transcripts coding for hexon and penton pro-
teins. The expected size fragments of 700 and 650 bpCSL503 12 / / ND / / / /
24 / / / / 0 / / were produced for penton and hexon, respectively, at
48 / / / / ND ND / both 24 and 48 h p.i. in ovine cells (Fig. 7, top, lanes 2
MRC-5c 48 0 / 0 / / / 0 and 4; middle, lanes 4 and 6). However, these products
96 / / 0 / 0 / /
could not be detected in PC-3, T47-D2, MCF-7, MRC-5,PC-3c 48 0 / 0 / 0 / 0
and RK13 cell lines infected with OAV206 even at times144 0 / 0 / / / 0
T47D-2c 48 0 / 0 / / / 0 as late as 96 and 144 h p.i. (Fig. 7, top, even numbered
MCF-7c 48 0 / 0 / 0 / 0 lanes 6–28, inclusive; middle, even numbered lanes 8–
RK13c 48 0 / 0 / / / 0 22, inclusive). As a control for all the above RT-PCR anal-
HT29d 48 0 ND 0 0 0 0 ND
yses, each cDNA preparation produced the expected96 0 / 0 0 0 0
product corresponding to a portion of the cellular GAPDHHEPG2d 48 0 0 0 0 0 0 ND
96 0 0 / 0 0 0 mRNA when appropriate primers were used (Table 1;
Fig. 7, bottom, lanes 1–22).
Note. ND, not done.
a Hours post infection. Promoter activity in cells infected at a higher m.o.i.b LHP2 transcripts include those initiated at LHP1.
c m.o.i. 20 PFU/cell. Although transcripts could be detected in cells infected
d m.o.i. 100 PFU/cell. with OAV at an m.o.i. of 20, a more stringent analysis of
promoter activity was carried out using a higher m.o.i.
HepG2 and HT29 cells were infected with OAV at anE4P2) that lie in the A/T-rich region of the genome
m.o.i. of 100 PFU/cell and mRNA was prepared. RT-PCRwhich was previously of unknown function (Vrati et al.,
analysis showed that at 48 h p.i. the hexon product was1996a). RT-PCR analysis of this transcript shows that
readily detectable in CSL503 cells (infected at m.o.i. 20)these promoters are differentially active in an ovine and
(Fig. 8, lane 2) but not in HepG2 cells (Fig. 8, lane 4; Tablesome human cell types (infected at an m.o.i. of 20 – 100
2). A trace of hexon product may have been detected atPFU/cell), with the E4P2 being more active. However,
96 h p.i. (Fig. 8, lane 5). In contrast to the other cell types,neither promoter was active in HepG2 or HT29 cells
no E2 promoter activity was detected in HepG2 liver cells(Table 2).
at 48 or 96 h p.i. (Fig. 8, lanes 9 and 10). Similarly, theTwo spliced transcripts derived from an early promoter
LHP1 promoter was active in CSL503 cells, producing anear the right-hand end of the genome were detected by 530-bp PCR product (Fig. 8, lane 12), but not detectablyRT-PCR in CSL503 cells (Xu et al., 1997). The PCR prod-
active in HepG2 cells (Fig. 8, lanes 14, 15). However, theucts of 750 and 550 bp are shown in Fig. 6 (lanes
appropriate GAPDH product was obtained in each case2, 4, and 6). A 2.7-kb fragment probably produced by
(Fig. 8, bottom). In addition, the LHP2 and E4 promotersamplification of residual viral DNA in the mRNA was also
were also inactive in HepG2 cells (Table 2). Essentiallyevident at 48 h (lane 6). In the other infected cell lines
analyzed, the PCR products were detected only at 96 h
p.i. in MRC-5 cells (Fig. 6, lane 14) and their appearance
was significantly delayed in comparison with permissive
cells. The band at 900 bp was not considered signifi-
cant as it also appeared in uninfected PC-3 and MRC-5
cells (Fig. 6, lanes 9 and 13, respectively). The 2.7-kb
genome product was not detected in MRC-5 cells (lane
14), suggesting that viral DNA replication had not oc-
curred in those cells.
MLP function in infected cells
FIG. 5. Analysis of DBP transcripts from the E2 promoter in humanThe fact that VP7sc expression by OAV204 was re-
cell types. mRNA samples prepared from uninfected (odd numbered
stricted to permissive cells suggested that ectopically lanes) and OAV-infected cells (m.o.i. of 20 PFU/cell) (even numbered
located MLP/TLS sequences did not function in the ab- lanes) were amplified by RT-PCR using DBP primers and analysed on
an agarose gel.sence of virus replication. To determine whether the en-
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FIG. 6. Analysis of right-hand end transcripts in OAV206-infected cells. At the times indicated mRNAs were prepared from uninfected and infected
cells (odd and even numbered lanes, respectively), RT-PCR amplified and analyzed by agarose gel electrophoresis. CSL503 (lanes 1–6), PC-3 (lanes
7–10), MRC-5 (lanes 11–14), T47–D2 (lanes 15, 16), McF-7 (lanes 17, 18), RK (lanes 19, 20), LNCaP (lanes 21, 22). M, markers of 3.0, 1.4, 0.76,
0.53, and 0.23 kb. An inverted gray-scale image of the ethidium bromide-stained gels is shown.
identical results to those obtained for HepG2 cells were However, the medium from MRC-5 cells contained little
or no virus as no staining was detected (Fig. 9D). In aobtained when HT29 cells were infected with OAV206 at
m.o.i. 100 (Table 2). further experiment, OAV216 was passaged twice in MRC-
5 cells and assayed on permissive CSL503 cells. Medium
OAV does not replicate in human cells (200 ml) harvested at 74 h p.i. from OAV216-infected MRC-
5 cells (m.o.i. 100) was used to reinfect MRC-5 cells. NoDuring Ad2 infection, the switch to late transcription
deterioration of the monolayer was observed after 72 h.requires DNA replication and a cis-acting change in the
When 10% of the lysate derived from these cells wasviral chromatin (Thomas and Mathews, 1980). Thus, the
passaged on CSL503 cells, no cpe was observed afterabsence of OAV MLP function might have been due to
9 days (data not shown). Thus, there was no evidencea lack of DNA replication. To investigate this, MCF-7,
for replication of OAV or its DNA following infection ofHepG2, and MRC-5 cells were infected with OAV216 at
MRC-5 cells, even starting at an m.o.i. of 100.m.o.i.s of 0–100 PFU/cell. Control CSL503 cells were
infected at m.o.i.s of 0, 1, and 10. After infection, the
DISCUSSIONinoculum was removed and the cells were washed twice
with PBS. A portion of each culture medium was retained We have described the construction and properties of
recombinants derived from an ovine adenovirus whichwhen cells were harvested. Low-molecular-weight DNA
was recovered from the cells by lysis in SDS and diges- is phylogenetically distinct from the Mastadenoviruses
and the Aviadenoviruses (Harrach et al., 1997). Trans-tion with pronase. DNA samples were digested with NheI
to highlight any OAV genome fragments and analyzed by gene cassettes were assembled in a separate plasmid
and subcloned into nonessential site I of the OAV ge-agarose gel electrophoresis. In permissive CSL503 cells
OAV DNA was amplified by 54 h p.i. in proportion to nome (Vrati et al., 1996c) without the introduction of a
compensating deletion. Recombinants carried insertionsthe m.o.i. (Fig. 9A, lanes 2 and 3). In contrast, no DNA
replication was detected at 94 h p.i. in MCF-7, HepG2, of up to 3.1 kb in size, but the virus has the capacity to
carry transgenes of at least 4.3 kb and theoretically 6.3HFF (data not shown), or MRC-5 cells (Fig. 9B, lanes 2–
6), although the input DNA may have been detectable at kb in size (Xu et al., 1997). Expression of the reporter
gene VP7sc (in OAV204 and OAV206) or AP (in OAV216)the m.o.i.s 10 and 20 (lanes 3 and 4) when the cell mono-
layer was better preserved. In similar experiments, no was readily observed in permissive CSL503 cells using
the OAV MLP (Vrati et al., 1996b) or the HCMV promoter,OAV DNA replication was detected in MRC-5 cells in-
fected at m.o.i.s of 200 and 500 (data not shown). although no attempt has yet been made to optimize the
structure of transgene gene cassettes to maximize ex-As the most sensitive indicator of viral replication, the
production of infectious virus, was monitored. MRC-5 and pression.
The availability of these recombinants facilitated theCSL503 cells were infected at m.o.i.s of 100 and 10,
respectively. The inoculum was removed and the cells investigation of OAV host range. Cells which were per-
missive for OAV replication included the ovine fetal lungwashed. At 94 or 55 h p.i., respectively, cells in both
cultures showed cpe (Fig. 9C). Medium (200 ml) from line, CSL503, and, to a lesser extent, BNT cells. All other
animal and human lines tested so far were nonpermis-these cultures was used to infect MCF-7 indicator cells
to determine whether any OAV216 virus was present. sive at the m.o.i.s tested (this work and (Boyle et al.,
1994). Cells were variously infected at multiplicities ofCells were stained for AP expression at 96 h p.i. The
medium from CSL503 cells contained virus, as expected, 20–100 PFU/cell as determined by plaque assays on
CSL503 cells. However, based on particle number (Mit-because many MCF-7 cells stained positively (Fig. 9D).
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FIG. 7. Analysis of penton, hexon, and GAPDH transcripts in OAV206-infected cells. mRNA prepared from OAV-infected (m.o.i. 20 PFU/cell) (even
numbered lanes) or mock-infected cells (odd numbered lanes) at 24–144 h p.i., as indicated, was used for cDNA synthesis. cDNAs amplified by
PCR were analyzed by agarose gel electrophoresis. (Top) (penton): mRNA from CSL503 (lanes 1–4), RK (lanes 5–8), PC-3 (lanes 9–12), MRC-5
(lanes 13–16), MCF-7 (lanes 17 –20), LNCaP (lanes 21–24), and T47-D2 cells (lanes 25–28). (Middle) hexon and (bottom) (GAPDH analysis); mRNAs
prepared at 12–96 h p.i. as indicated were used to analyze hexon and GAPDH transcripts in infected cells; CSL503 (lanes 1–6), PC-3 (lanes 7–
10), MRC-5 (lanes 11–14), T47-D2 (lanes 15, 16), McF-7 (lanes 17, 18), RK (lanes 19, 20), LNCaP (lanes 21, 22). Lane 23 (lower panel) was a positive
plasmid control for GAPDH analysis. LNCaP are negative control cells which are not infected by OAV. The M lane contains size markers of 1.4,
0.76, 0.53, and 0.23 kb. Inverted gray-scale images of the ethidium bromide-stained gels are shown.
tereder et al., 1996) the multiplicity per cell was probably penton completely lacks this domain (Vrati et al., 1996a)
or at best, has a sequence SVDVNDA which does notmuch higher.
Infection by human Ads is mediated by attachment of contain a known integrin binding motif. Therefore, it is
not clear whether OAV is capable of interacting withthe fiber protein (Philipson et al., 1968) to a primary re-
ceptor which has now been identified (Bergelson et al., integrins. Perhaps, if the virus is unable to interact with
a secondary receptor, it may still infect cells by attaching1997). A secondary interaction between an RGD motif in
a loop of the penton base protein and certain classes of to a primary receptor that becomes internalized by endo-
cytosis. This may require multiple primary attachmentsintegrins, principally avbv and avb3 , facilitates internaliza-
tion by endocytosis (Wickham et al., 1993; Mathias et al., (Freimuth, 1996). As parameters such as adsorption vol-
ume and time can significantly affect the number of trans-1994). It is therefore of interest that OAV infects a range
of human cell types in spite of the differences between duced cells (Mittereder et al., 1996) and these have not
been optimized for OAV infection, there may be scopethe OAV fiber and penton proteins and the Ad5 homologs.
The shafts of Ad5 and OAV fibers contain a different for improvement of transduction efficiencies. The inability
of OAV to infect human cells such as LNCaP and 293number of repeat structures and their cell attachment
domains are completely different in size and sequence presumably reflects the absence or low copy number of
its primary receptor. These negative cell lines also serve(Vrati et al., 1995). It seems unlikely, therefore, that Ad5
and OAV bind to the same primary receptor, although, as controls to show that in the presence of 10–100 PFU/
cell of OAV (which probably represents a higher particleconsidering the variety of cell types infected, both recep-
tors are apparently widespread. In the penton protein of number (Mittereder et al., 1996)), virus uptake does not
occur by a nonspecific process.fowl Ad and human Ads types 2, 12, and 40, sequences
flanking the RGD domain have clear homology to OAV OAV recombinants infected a variety of nonovine cells
but, with the exception of BNTs, replication was abortive,(Vrati et al., 1996a). The human Ads all have a short
sequence containing RGD or a similar motif; avian Ad despite the fact that all OAV genes were present. We
attempted to ascertain where the block(s) to replicationhas a different sequence (Bai et al., 1993). However, OAV
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occurred in the absence of virus replication requires fur-
ther investigation.
The E2 promoter, which controls DBP, TP, and DNA
polymerase expression was active in many nonpermis-
sive cell types and therefore, these viral components
were unlikely to have been limiting for genome replica-
tion. However, no viral DNA replication was detected in
any nonpermissive cells, although we cannot rule out
that a very low level occurred. As cellular factors are also
involved in DNA replication (reviewed in Shenk, 1996), its
FIG. 8. Analysis of promoter function in HepG2 cells. mRNA was
prepared from OAV-infected (m.o.i. 100 PFU/cell) (even numbered
lanes) and uninfected cells (odd numbered lanes) at the times indicated
and cDNA was synthesized. RT-PCR was carried out using primers
specific for hexon, DBP and LHP1 transcripts at the left-hand end of
the genome, and products were analysed on an agarose gel. The arrow
indicates the pair of virus-specific transcripts (lane 12) from the LHP1
promoter. The lower panel shows the GAPDH RT-PCR products ampli-
fied from RNA prepared from uninfected and OAV-infected CSL503 and
HepG2 cells at 48 and 96 hr RNAs as indicated.
occurred by examining the activity of various promoters
in nonpermissively infected cells. We are in the process
of defining a transcription map of the OAV genome and
have identified several transcription start sites by RLM/
RACE/PCR (Schaeffer, 1995) and numerous spliced
RNAs by RT-PCR and cloning. Transcripts and the ap-
proximate location of early promoters for regions E2 and
E4 and the left-hand end of the genome have thus been
identified (Khatri and Both, manuscript in preparation).
The MLP and right-hand end promoters were identified
previously (Vrati et al., 1996b; Xu et al., 1997). RT-PCR
was used to monitor promoter activity in the various cell
types. Early promoters at the left- and right-hand ends
of the genome as well as those for E2 and E4 were all
active in MRC-5 cells. RK cells had a similar profile. MCF-
7 cells were representative of cells where some, but not
FIG. 9. Replication of OAV DNA in permissive and nonpermissiveall, early promoters were active at a low level at 48 h p.i.
cells. (A) CSL503 cells (permissive) were infected with OAV216 at theIn contrast, none of the promoters analyzed was signifi-
M.O.I.s indicated (PFU/cell) and harvested at 54 h p.i. (B) MRC-5 cellscantly active in HepG2 cells and only the LHP2 promoter
were infected as indicated and harvested at 94 h p.i. Hirt DNAs were
was active in HT29 cells. Thus, abortive replication in extracted, digested with NheI, and analyzed on an agarose gel. Viral
some cell types was due to the complete or partial ab- DNA bands of 11.5, 11.1, 8.3, and 1.6 kb were expected. Lanes (M)
contain markers of the sizes indicated (in kb) in A. Inverted images ofsence of early promoter function. In addition, there was
ethidium bromide stained gels are shown. Panels in C show CSL503an inverse correlation between promoter activity and
at 55 hr p.i. (left) and MRC-5 cells (right) at 94 hr p.i. after infection atpreservation of the cell monolayer, i.e., most promoters m.o.i.s of 10 and 100, respectively, with OAV216. In D, medium (200
were active in MRC-5 cells which showed the greatest ml) from the cultures in C was used to infect MCF-7 cells. Cells were
stained for AP expression at 96 h p.i.signs of cpe after 3–4 days. The nature of this cpe which
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